The enigmatic role of angiopoietin-1 in tumor angiogenesis

被引:82
作者
Metheny-Barlow, LJ
Li, YL
机构
[1] Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA 15213 USA
[2] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA
关键词
angiopoietin; angiogenesis; cancer; endothelial cells; mural cells;
D O I
10.1038/sj.cr.7290176
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
A tumor vasculature is highly unstable and immature, characterized by a high proliferation rate of endothelial cells, hyper-permeability, and chaotic blood flow. The dysfunctional vasculature gives rise to continual plasma leakage and hypoxia in the tumor, resulting in constant on-sets of inflammation and angiogenesis. Tumors are thus likened to wounds that will not heal. The lack of functional mural cells, including pericytes and vascular smooth muscle cells, in tumor vascular structure contributes significantly to the abnormality of tumor vessels. Angiopoietin-1 (Ang1) is a physiological angiogenesis promoter during embryonic development. The function of Ang 1 is essential to endothelial cell survival, vascular branching, and pericyte recruitment. However, an increasing amount of experimental data suggest that Ang 1-stimulated association of mural cells with endothelial cells lead to stabilization of newly formed blood vessels. This in turn may limit the otherwise continuous angiogenesis in the tumor, and consequently give rise to inhibition of tumor growth. We discuss the enigmatic role of Ang I in tumor angiogenesis in this review.
引用
收藏
页码:309 / 317
页数:9
相关论文
共 115 条
  • [1] Analysis of mural cell recruitment to tumor vessels
    Abramsson, A
    Berlin, Ö
    Papayan, H
    Paulin, D
    Shani, M
    Betsholtz, C
    [J]. CIRCULATION, 2002, 105 (01) : 112 - 117
  • [2] Ahmad SA, 2001, CANCER, V92, P1138, DOI 10.1002/1097-0142(20010901)92:5<1138::AID-CNCR1431>3.0.CO
  • [3] 2-L
  • [4] Ahmad SA, 2001, CANCER RES, V61, P1255
  • [5] AN ACTIVATED FORM OF TRANSFORMING GROWTH FACTOR-BETA IS PRODUCED BY COCULTURES OF ENDOTHELIAL-CELLS AND PERICYTES
    ANTONELLIORLIDGE, A
    SAUNDERS, KB
    SMITH, SR
    DAMORE, PA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (12) : 4544 - 4548
  • [6] Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors
    Arsic, N
    Zentilin, L
    Zacchigna, S
    Santoro, D
    Stanta, G
    Salvi, A
    Sinagra, G
    Giacca, M
    [J]. MOLECULAR THERAPY, 2003, 7 (04) : 450 - 459
  • [7] Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization
    Asahara, T
    Chen, DH
    Takahashi, T
    Fujikawa, K
    Kearney, M
    Magner, M
    Yancopoulos, GD
    Isner, JM
    [J]. CIRCULATION RESEARCH, 1998, 83 (03) : 233 - 240
  • [8] Expression of angiopoietin-1 in human glioblastomas regulates tumor-induced angiogenesis - In vivo and in vitro studies
    Audero, E
    Cascone, I
    Zanon, I
    Previtali, SC
    Piva, R
    Schiffer, D
    Bussolino, F
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) : 536 - 541
  • [9] Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
    Benjamin, LE
    Golijanin, D
    Itin, A
    Pode, D
    Keshet, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) : 159 - 165
  • [10] Brown LF, 1999, CLIN CANCER RES, V5, P1041